Daratumumab (Darzalex)
Drug timelines are a Plus or Pro feature.
24 regulatory and trial events tracked for Daratumumab (Darzalex), covering 2022-02-17 to 2026-04-16. Get the full timeline:
Most recent: Clinical Trial Update: A Study of CyBorD (Cyclophosphamide, Bortezomib, Dexamethasone) Plus Daratumumab in People With Monoclonal Gammopathy of Renal Significance (MGRS) [Phase 2]